Labshake search
Citations for R&D Systems :
551 - 600 of 1191 citations for 3 hydroxy 20 oxopregn 5 en 21 yl acetate since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Genetics 2023Quote: ... and recombinant human FGF2 at 20 ng/uL (R&D systems #233-FB-010).
-
bioRxiv - Immunology 2022Quote: ... the cells were treated with 20 – 100 U/ml IFN-γ (R&D Systems) and 1 μM TPI peptide (Genscript).
-
bioRxiv - Developmental Biology 2022Quote: ... and supplemented with the growth factors EGF (20 ng ml−1; R&D Systems) and FGF2 (20 ng ml−1 ...
-
bioRxiv - Bioengineering 2024Quote: ... 20 ng/mL human basic fibroblast growth factor (b-FGF) (R&D Systems, Inc.), and 10 μM Y27632 (FUJIFILM Wako Pure Chemical Corporation ...
-
bioRxiv - Neuroscience 2024Quote: ... and 20 ng ml−1 basic fibroblast growth factor (R&D Systems, 233-FB), with every day medium change for another 8 days ...
-
bioRxiv - Microbiology 2023Quote: ... supplemented with 20 ng/mL of recombinant human oncostatin M (OSM, R&D systems). For the co-culture experiment ...
-
bioRxiv - Biophysics 2022Quote: ... the cells were treated with 20 – 100 U/ml IFN-γ (R&D Systems) and 1 μM TPI peptide (Genscript ...
-
bioRxiv - Immunology 2023Quote: ... supplemented with 20 ng/mL of recombinant mouse interleukin (IL)- 2 (R&D systems), 8% CTS Immune Cell Serum Replacement (Thermo Fisher) ...
-
bioRxiv - Immunology 2024Quote: ... Cultures were then treated with 20 μg/ml DC-SIGN-Fc (R&D Systems), or the indicated concentration of anti-Igκ F(ab’)2 ...
-
bioRxiv - Cancer Biology 2024Quote: ... 10% FBS and 20 ng/ml GM-CSF (R&D Systems, 415-ML-010). Half of the medium was removed on day 2 and replenished with warmed complete RPMI medium with 40 ng/ml GM-CSF and 10 ng/ml IL-4 (Biolegend ...
-
bioRxiv - Developmental Biology 2021Quote: ... sheep anti-PAX6 (AF8150: R&D Systems, 5 µg/mL); rat anti-TBR2 (clone ...
-
Optimization of AAV6 transduction enhances site-specific genome editing of primary human lymphocytesbioRxiv - Molecular Biology 2021Quote: ... 5 μg/mL soluble CD40L (R&D Systems, Minneapolis, MN), 10 μg/mL anti-His tag antibody (clone AD1.1.10 ...
-
bioRxiv - Microbiology 2021Quote: ... LL-37 (5 – 40 μg ml−1, R&D Systems), hNP-1 (0.625 – 10 μg ml−1 ...
-
bioRxiv - Bioengineering 2020Quote: ... 5 ng/ml hbFGF (233-FB; R&D systems, USA), and 1X Pen/Strep.
-
bioRxiv - Biophysics 2021Quote: ... and 5 ng/mL bFGF (R&D Systems, 223-FB). To avoid interference from lamellipodial protrusion/retraction cycles on T-Plastin recovery measurements ...
-
bioRxiv - Cell Biology 2021Quote: ... 5 μM of RepSox (R) (R&D Systems, 3742/50) and 3 μM of CHIR99021 (C ...
-
bioRxiv - Developmental Biology 2022Quote: ... 5 ng/ml basic fibroblast growth factor (R&D Systems), and 250 nM SANT1 (Cayman) ...
-
bioRxiv - Cancer Biology 2020Quote: ... 5 ng/ml recombinant murine IL-4 (R&D Systems), and 5 ng/ml recombinant human TGF-β (R&D Systems) ...
-
bioRxiv - Genomics 2021Quote: ... and E-cadherin (5 µg/ml, R&D Systems, #AF648) overnight ...
-
bioRxiv - Developmental Biology 2021Quote: ... 5 ng/ml mouse VEGF (R&D systems Cat. 494MV). For mesoderm induction in the AB regimen ...
-
bioRxiv - Immunology 2020Quote: ... and Mouse IL-5 Quantikine ELISA Kit (R&D System). The OD450 values were read by Multiskan GO (ThermoFisher).
-
bioRxiv - Developmental Biology 2023Quote: ... 5 ng/ml SHH (R&D Systems, cat# 8908-SH), 2 ng/ml JAG1 (1277-JG-050 ...
-
bioRxiv - Cancer Biology 2023Quote: ... 5 μM Q-VD-OPh (R&D Systems, Abindgon, UK).
-
bioRxiv - Cancer Biology 2023Quote: ... TNFα (5 ng/m; R&D systems #210-TA-020) and IFNγ (25 IU/mL ...
-
bioRxiv - Developmental Biology 2024Quote: ... 5 ng/mL VEGF (R&D Systems 293-VE-050), and 5 μL/mL Transferrin ...
-
bioRxiv - Developmental Biology 2024Quote: ... 5 ng/mL bFGF (R&D Systems 233-FB-025), and 5 μL/mL Transferrin (Roche 10652202001) ...
-
bioRxiv - Immunology 2024Quote: ... recombinant mouse IL-17A (5 ng/mL; R&D Systems); or the appropriate vehicles and carrier proteins for 24 h ...
-
bioRxiv - Microbiology 2024Quote: ... Z-vad (5 µM, Pan-caspase inhibitor, R&D systems), Z-vad plus SopB (3 µg/mL ...
-
bioRxiv - Developmental Biology 2024Quote: ... and Activin A (5 ng ml-1; R&D Systems) for 24 hr.
-
bioRxiv - Bioengineering 2024Quote: ... which consists of 5% FCS (R&D systems, Cat #M19187), 5 ng μl−1 IL-7 ...
-
bioRxiv - Biochemistry 2024Quote: ... mouse anti-IL10RB (R&D Systems MAB874, 5 μg/ml), rabbit anti-FOXO3 (CST 2497 ...
-
bioRxiv - Developmental Biology 2024Quote: ... and Activin A (5 ng ml-1; R&D Systems) for 48 hr ...
-
bioRxiv - Bioengineering 2021Quote: ... and Human chitinase 3-like 1 (YKL-40) were purchased from R&D Systems. Bovine serum albumin was purchased from Sigma Aldrich ...
-
bioRxiv - Microbiology 2021Quote: ... and Human IL29/IL28B (IFN-lambda 1/3) DuoSet ELISA (DY1598B, R&D Systems). Protein levels of IFNλ from intestinal biopsies were measured by Mouse IL28B/ IFN-lambda 3 DuoSet ELISA (DY1789B ...
-
bioRxiv - Cancer Biology 2022Quote: ... cocultures were treated with 3 μg/ml IL1α-neutralizing antibody (#MAB4001, R&D Systems) or isotype control antibody (#400902 ...
-
bioRxiv - Molecular Biology 2022Quote: ... Recombinant human WNT3A and R-spondin 3 were from R&D Systems (Minneapolis, USA).
-
The transcription factor RUNX2 drives the generation of human NK cells and promotes tissue residencybioRxiv - Immunology 2022Quote: ... FMS-like tyrosine kinase-3 ligand (FLT3-L) (100 ng/mL, R&D systems) and thrombopoietin (TPO ...
-
bioRxiv - Microbiology 2023Quote: Calu-3 cells were treated with exogenous β-IFN (R&D Systems, Minneapolis MN), baricitinib (Selleck Chemicals ...
-
bioRxiv - Microbiology 2023Quote: ... or 3 ug/ml of an anti-Dectin-1 antibody (MAB1859; R&D Systems). Mouse IgG was used as a control ...
-
bioRxiv - Immunology 2024Quote: ... 2mM L-Glutamine and 20ng/mL of recombinant human IL-3 (R&D systems). Cas9 and gRNA components were assembled into RNP per the manufacturer’s instructions and transfected into pDC 16 hrs p.c ...
-
bioRxiv - Neuroscience 2023Quote: cleaved caspase 3 (Cat. No. MAB835, 1:200 in blocking solution, R&D Systems), dsDNA (Cat No ...
-
Low-dose cytokine immunotherapy of solid cancers enabled by phagocytic-competent protein co-crystalsbioRxiv - Cancer Biology 2023Quote: ... 3 and 6 days and subsequently tested by IL-2 ELISA (R&D Systems) according to the manufacturer’s protocol.
-
bioRxiv - Genomics 2024Quote: ... M anti-DENV NS1 (Type 2/3/4) (Cat# MAB94441-100, R&D Systems), M anti-NXT1 (Cat#67680-1-Ig ...
-
bioRxiv - Developmental Biology 2024Quote: ... 10 ng/ml IL-3 and 80 ng/ml M-CSF (R&D Systems). On day 13 ...
-
bioRxiv - Neuroscience 2020Quote: ... 20 ng/ml FGF2 and 40 ng/ml BMP (R&D Systems, 314-BP-050) in CDM2 basal media for 24 hr ...
-
bioRxiv - Genomics 2020Quote: ... 20 mM HEPES) supplemented with 60 ng/mL recombinant mouse M-CSF (R&D systems). For analysis of proliferation ...
-
bioRxiv - Microbiology 2021Quote: ... Replacement of CHIR99021 by 20 ng/mL FGF-2 (223-FB-500, R&D Systems), followed by maintenance in 15 ng/mL VEGF and 5 ng/mL FGF-2 induced differentiation into the hematopoietic lineage according to a modified protocol from Grigoriadis et al ...
-
bioRxiv - Cell Biology 2021Quote: ... cells were treated with 20 ng of TNF-α (R&D systems, 10291-TA-020) for 24 hours ...
-
bioRxiv - Cell Biology 2022Quote: ... the plate was washed (0.05% Tween 20 in PBS) and blocked (R&D system, DY995) at room temperature using the reagent diluent for 2 hours ...
-
bioRxiv - Immunology 2022Quote: ... supplemented with 20 ng/ml of recombinant murine GM-CSF (rmGM-CSF, R&D systems). Plates were incubated in humidified atmosphere at 37°C ...